Accelerated Phenotyping and Biomarker Structural Elucidation at the National Phenome Centre

April 24, 2019

Webinar Overview

To solve today’s challenges in Metabolomics research, analytical instrumentation and software need to be seamlessly integrated to provide high quality data for biological interpretation. As biobanks and clinics open their doors to the promise of metabolic phenotyping for understanding population health, powerful analytical solutions capable of large-scale deployment are becoming mission-critical. Join Dr. Lewis for his webinar “Accelerated phenotyping and biomarker structural elucidation at the National Phenome Centre” to learn more about addressing these needs through complementary MS (TOF and MRMS) and NMR solutions.

Key Learnings

  • Complete Phenomics Solution: NMR, MRMS, TOF-structure, molecular formula and msms profiling, and complete software solutions

Who Should Attend?

  • Anyone using NMR, Metabolomics researchers, lab managers


Mathew R. Lewis

Chief Operations Officer MRC- NIHR National Phenome Centre

Matthew joined the Department of Surgery and Cancer at Imperial College London (ICL) in 2010 after successfully working to establish a metabolomics program in the core research facility at Colorado State University. He was recruited to ICL to oversee mass spectrometry operations within the Division of Computational Systems Medicine which have since grown to include the BRC Clinical Phenotyping Centre and, following the 2012 London Olympics, the MRC-NIHR National Phenome Centre (NPC). As the Chief Operations Officer for the NPC, Matthew is responsible for the development and execution of analytical strategies as well as the Centre’s portfolio of research collaborations, overseeing them from design to delivery. His research focuses on the development and application of high precision methods for metabolic phenotyping in clinical medicine and population health, as well as the development of metabolite assignment and identification resources and capability.


For Research Use Only. Not for use in clinical diagnostic procedures.